# Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial

> **NCT02002052** · PHASE2 · TERMINATED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 29 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Concurrent platinum-based chemotherapy
- **RADIATION:** Standard Radiotherapy, 60 Gy in 30 fractions.
- **RADIATION:** Functional Lung Avoidance Radiotherapy, 60 Gy in 30 fractions

## Key facts

- **NCT ID:** NCT02002052
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05
- **Primary completion:** 2017-01
- **Final completion:** 2017-01
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Insufficient accrual
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02002052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02002052, "Functional Lung Avoidance for Individualized Radiotherapy (FLAIR): A Randomized, Double-Blind Clinical Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02002052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*